Published in Nat Neurosci on December 27, 2009
Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat Neurosci (2011) 5.40
Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci (2010) 5.03
Alzheimer's disease: the challenge of the second century. Sci Transl Med (2011) 4.88
The amyloid state of proteins in human diseases. Cell (2012) 4.53
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol (2012) 3.48
Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med (2012) 2.77
Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med (2012) 2.56
Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron (2010) 2.10
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A (2013) 1.73
Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol (2012) 1.57
The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation. Neuron (2013) 1.43
Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J Neurosci (2011) 1.43
CaMKII: claiming center stage in postsynaptic function and organization. Neuron (2014) 1.39
Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J (2013) 1.31
Mechanisms and function of dendritic exocytosis. Neuron (2011) 1.28
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol (2012) 1.26
Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression. Proc Natl Acad Sci U S A (2013) 1.22
Amyloid-β as a modulator of synaptic plasticity. J Alzheimers Dis (2010) 1.22
Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron (2013) 1.21
Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS One (2010) 1.17
Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta Neuropathol Commun (2014) 1.16
The dendritic hypothesis for Alzheimer's disease pathophysiology. Brain Res Bull (2013) 1.14
CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. J Cell Sci (2010) 1.11
Synapse-to-nucleus signaling. Curr Opin Neurobiol (2011) 1.06
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease. Nat Commun (2012) 1.06
Spines, plasticity, and cognition in Alzheimer's model mice. Neural Plast (2011) 1.06
In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks. Acta Neuropathol (2010) 1.05
Opposing synaptic regulation of amyloid-β metabolism by NMDA receptors in vivo. J Neurosci (2011) 1.04
Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp Brain Res (2011) 1.03
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem Pharmacol (2014) 1.01
Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. J Neurosci (2014) 1.00
Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci (2013) 0.99
Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment. J Neurosci (2014) 0.95
New developments on the role of NMDA receptors in Alzheimer's disease. Curr Opin Neurobiol (2011) 0.93
Identification of NEEP21 as a ß-amyloid precursor protein-interacting protein in vivo that modulates amyloidogenic processing in vitro. J Neurosci (2010) 0.93
Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change. Nat Neurosci (2013) 0.92
Neuronal endoplasmic reticulum stress in axon injury and neurodegeneration. Ann Neurol (2013) 0.92
Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease. J Alzheimers Dis (2012) 0.91
Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice. Brain Res (2011) 0.91
PTEN recruitment controls synaptic and cognitive function in Alzheimer's models. Nat Neurosci (2016) 0.90
High-throughput single-cell manipulation in brain tissue. PLoS One (2012) 0.89
SUMO and Alzheimer's disease. Neuromolecular Med (2013) 0.89
Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects. Hum Mol Genet (2012) 0.89
Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease. Front Physiol (2012) 0.89
Ubiquitin-dependent endocytosis, trafficking and turnover of neuronal membrane proteins. Mol Cell Neurosci (2011) 0.89
New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis (2011) 0.89
Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun (2012) 0.88
NMDA receptors and BAX are essential for Aβ impairment of LTP. Sci Rep (2012) 0.88
PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices. Exp Neurobiol (2013) 0.87
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics. Alzheimers Res Ther (2014) 0.86
Centaurin-α1-Ras-Elk-1 signaling at mitochondria mediates β-amyloid-induced synaptic dysfunction. J Neurosci (2013) 0.85
Differential release of β-amyloid from dendrite- versus axon-targeted APP. J Neurosci (2014) 0.85
Synapto-depressive effects of amyloid beta require PICK1. Eur J Neurosci (2014) 0.85
Excitability and synaptic alterations in the cerebellum of APP/PS1 mice. PLoS One (2012) 0.85
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits. PLoS One (2014) 0.85
Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy. Int J Alzheimers Dis (2012) 0.84
CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton. PLoS One (2011) 0.84
The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease-old wine in new bottles. Front Mol Neurosci (2012) 0.83
Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation. Front Aging Neurosci (2014) 0.82
Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex. Brain Struct Funct (2015) 0.82
FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing. J Neurochem (2011) 0.82
Attenuation of β-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity. J Neurosci (2016) 0.81
Regulation of neuronal gene expression and survival by basal NMDA receptor activity: a role for histone deacetylase 4. J Neurosci (2014) 0.81
Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease. Sci Signal (2016) 0.81
The role of activity in synaptic degeneration in a protein misfolding disease, prion disease. PLoS One (2012) 0.81
Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments. Front Comput Neurosci (2012) 0.81
High-throughput sequencing of the synaptome in major depressive disorder. Mol Psychiatry (2015) 0.81
Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway. Acta Pharmacol Sin (2014) 0.80
Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid. J Aging Res (2013) 0.80
Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology. Cereb Cortex (2015) 0.80
STAT1 negatively regulates spatial memory formation and mediates the memory-impairing effect of Aβ. Neuropsychopharmacology (2013) 0.79
Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing. Mol Biol Cell (2014) 0.79
Possible contributions of a novel form of synaptic plasticity in Aplysia to reward, memory, and their dysfunctions in mammalian brain. Learn Mem (2013) 0.79
Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease. J Neural Transm (Vienna) (2015) 0.79
Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions. Neurobiol Dis (2012) 0.79
Local and Use-Dependent Effects of β-Amyloid Oligomers on NMDA Receptor Function Revealed by Optical Quantal Analysis. J Neurosci (2016) 0.78
Postsynaptic target specific synaptic dysfunctions in the CA3 area of BACE1 knockout mice. PLoS One (2014) 0.78
Modeling presenilin-dependent familial Alzheimer's disease: emphasis on presenilin substrate-mediated signaling and synaptic function. Int J Alzheimers Dis (2010) 0.78
Delayed dendritic development in newly generated dentate granule cells by cell-autonomous expression of the amyloid precursor protein. Mol Cell Neurosci (2013) 0.78
Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease. Neurobiol Dis (2013) 0.77
The transcription factor XBP1s restores hippocampal synaptic plasticity and memory by control of the Kalirin-7 pathway in Alzheimer model. Mol Psychiatry (2016) 0.77
APP modulates KCC2 expression and function in hippocampal GABAergic inhibition. Elife (2017) 0.76
Silencing synapses: a route to understanding synapse degeneration in chronic neurodegenerative disease. Prion (2013) 0.76
β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition. Neuron (2014) 0.76
The Emergence of NMDA Receptor Metabotropic Function: Insights from Imaging. Front Synaptic Neurosci (2016) 0.76
Axonal Terminals Exposed to Amyloid-β May Not Lead to Pre-Synaptic Axonal Damage. J Alzheimers Dis (2015) 0.76
Non-ionotropic signaling by the NMDA receptor: controversy and opportunity. F1000Res (2016) 0.75
Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses. J Biol Chem (2016) 0.75
Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function. Sci Rep (2015) 0.75
Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization. Sci Rep (2017) 0.75
Simultaneous changes of spatial memory and spine density after intrahippocampal administration of fibrillar aβ1-42 to the rat brain. Biomed Res Int (2014) 0.75
Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3. Proc Natl Acad Sci U S A (2016) 0.75
Long-term depression-associated signaling is required for an in vitro model of NMDA receptor-dependent synapse pruning. Neurobiol Learn Mem (2016) 0.75
Mechanisms of Alzheimer's Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors. Clin Psychopharmacol Neurosci (2017) 0.75
Propagation of Neuronal Damage to Embryonic Grafts Transplanted in the Hippocampus of Murine Models of Alzheimer's Disease. Rejuvenation Res (2015) 0.75
Cooperation of Genomic and Rapid Nongenomic Actions of Estrogens in Synaptic Plasticity. Mol Neurobiol (2016) 0.75
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (2002) 19.36
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med (2008) 17.09
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci (2005) 12.85
Structural basis of long-term potentiation in single dendritic spines. Nature (2004) 11.50
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci (2004) 9.73
Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci (2005) 9.17
APP processing and synaptic function. Neuron (2003) 8.37
Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci (2007) 8.27
Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature (1999) 7.72
Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron (2005) 7.53
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (2001) 7.35
AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron (2006) 6.76
Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci (2007) 6.27
Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science (1999) 6.08
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol (2007) 5.48
Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci (2004) 5.10
Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron (2004) 4.88
Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci (2005) 4.71
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci (1999) 3.85
Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiation. J Neurosci (2006) 3.84
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 3.61
Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci U S A (1970) 3.48
Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med (2005) 3.28
Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci U S A (1990) 3.13
Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J Neurosci (2008) 2.77
Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron (2006) 2.76
Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol Biol Cell (2000) 2.73
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis (2005) 2.70
Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J Neurosci (2005) 2.57
Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci (2002) 2.35
Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci (1998) 2.00
Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease. J Neurosci (2005) 1.90
Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis (2003) 1.88
Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci (2001) 1.73
Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. J Neurophysiol (2003) 1.70
Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med (2007) 1.68
Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci (1993) 1.54
Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol Cell Neurosci (2007) 1.48
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol (2009) 1.44
Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc Natl Acad Sci U S A (2006) 1.44
Intraneuronal compartments of the amyloid precursor protein. J Neurosci (1993) 1.41
Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis. J Neurosci (2002) 1.41
beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem (2002) 1.32
Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons. Mol Cell Neurosci (2006) 1.28
Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci (2001) 1.17
Low-frequency activation of the NMDA receptor system can prevent the induction of LTP. Neurosci Lett (1989) 1.05
Abeta(1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis. J Neurosci Methods (2008) 1.04
Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo. Neuroreport (2004) 1.01
Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors. J Neurosci Methods (2004) 0.81
APP processing and synaptic function. Neuron (2003) 8.37
AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron (2006) 6.76
Postsynaptic receptor trafficking underlying a form of associative learning. Science (2005) 5.80
Synaptic AMPA receptor plasticity and behavior. Neuron (2009) 5.58
PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci (2003) 4.55
Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell (2002) 4.50
NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron (2005) 4.35
Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiation. J Neurosci (2006) 3.84
Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nat Neurosci (2003) 3.34
Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J Neurosci (2004) 3.30
Subunit-specific NMDA receptor trafficking to synapses. Neuron (2002) 3.16
Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron (2006) 3.02
Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell (2007) 3.00
Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature (2011) 2.98
The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron (2007) 2.96
Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron (2006) 2.79
AMPA receptor incorporation into synapses during LTP: the role of lateral movement and exocytosis. Neuron (2009) 2.64
Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med (2012) 2.56
PSD-95 is required for activity-driven synapse stabilization. Proc Natl Acad Sci U S A (2007) 2.56
Experience strengthening transmission by driving AMPA receptors into synapses. Science (2003) 2.34
GluR1 links structural and functional plasticity at excitatory synapses. J Neurosci (2007) 2.22
Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J (2004) 2.21
Optogenetic inhibition of synaptic release with chromophore-assisted light inactivation (CALI). Neuron (2013) 2.16
The prion protein as a receptor for amyloid-beta. Nature (2010) 2.10
βCaMKII in lateral habenula mediates core symptoms of depression. Science (2013) 1.96
Glutamate receptor subunit 2 Serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells. J Neurosci (2003) 1.90
Input to the lateral habenula from the basal ganglia is excitatory, aversive, and suppressed by serotonin. Neuron (2012) 1.77
Compartmentalized versus global synaptic plasticity on dendrites controlled by experience. Neuron (2011) 1.76
Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci (2007) 1.68
Multiple mechanisms for the potentiation of AMPA receptor-mediated transmission by alpha-Ca2+/calmodulin-dependent protein kinase II. J Neurosci (2002) 1.48
Roles of stargazin and phosphorylation in the control of AMPA receptor subcellular distribution. Nat Neurosci (2009) 1.45
Finite element analysis regarding patch size, stiffness, and contact condition to the endocardium in surgery for post infarction ventricular septal rupture. Gen Thorac Cardiovasc Surg (2013) 1.39
Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression. Proc Natl Acad Sci U S A (2013) 1.37
The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev (2009) 1.35
Serotonin mediates cross-modal reorganization of cortical circuits. Neuron (2011) 1.35
Cholinergic-mediated IP3-receptor activation induces long-lasting synaptic enhancement in CA1 pyramidal neurons. J Neurosci (2008) 1.29
Contextual learning requires synaptic AMPA receptor delivery in the hippocampus. Proc Natl Acad Sci U S A (2011) 1.28
Targeting the EphA4 receptor in the nervous system with biologically active peptides. Mol Cell Neurosci (2003) 1.24
Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression. Proc Natl Acad Sci U S A (2013) 1.22
Cellular pharmacology of protein kinase Mζ (PKMζ) contrasts with its in vitro profile: implications for PKMζ as a mediator of memory. J Biol Chem (2012) 1.21
Acute versus chronic NMDA receptor blockade and synaptic AMPA receptor delivery. Nat Neurosci (2002) 1.21
Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. Neuron (2003) 1.21
Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg (2008) 1.16
NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity. J Neurosci (2009) 1.04
Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp Brain Res (2011) 1.03
Disrupted cortical function underlies behavior dysfunction due to social isolation. J Clin Invest (2012) 1.01
Introduction of green fluorescent protein (GFP) into hippocampal neurons through viral infection. Cold Spring Harb Protoc (2010) 1.00
Critical postsynaptic density 95/disc large/zonula occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at different subcellular sites. J Neurosci (2002) 0.98
The developmental stages of synaptic plasticity. J Physiol (2013) 0.93
Neuroscience. Matters of size. Science (2006) 0.89
A robust automated method to analyze rodent motion during fear conditioning. Neuropharmacology (2006) 0.89
Two mutations preventing PDZ-protein interactions of GluR1 have opposite effects on synaptic plasticity. Learn Mem (2006) 0.88
GluA1 trafficking and metabotropic NMDA: addressing results from other laboratories inconsistent with ours. Philos Trans R Soc Lond B Biol Sci (2013) 0.88
T cell receptor CDR3 loops influence alphabeta pairing. Mol Immunol (2010) 0.86
Developmental AMPA receptor subunit specificity during experience-driven synaptic plasticity in the rat barrel cortex. Brain Res (2011) 0.86
Synapto-depressive effects of amyloid beta require PICK1. Eur J Neurosci (2014) 0.85
Neuroscience: Strength in numbers. Nature (2013) 0.85
A direct suture repair for a paravalvular leak 23 years after the second mitral valve replacements: A case report. Ann Thorac Cardiovasc Surg (2010) 0.84
Near-infrared-induced heating of confined water in polymeric particles for efficient payload release. ACS Nano (2014) 0.83
Alzheimer's disease: Recollection of lost memories. Nature (2011) 0.79
St. Jude prosthetic valve obstruction in the mitral position. Gen Thorac Cardiovasc Surg (2011) 0.78
A new series of estrogen receptor modulators: effect of alkyl substituents on receptor-binding affinity. Chem Pharm Bull (Tokyo) (2004) 0.77
Automatic tracking of the respiratory motion of lung parenchyma on dynamic magnetic resonance imaging: comparison with pulmonary function tests in patients with chronic obstructive pulmonary disease. J Thorac Imaging (2012) 0.76
Intracoronary adenosine triphosphate for refractory coronary artery spasm. Asian Cardiovasc Thorac Ann (2006) 0.75
[Ventricular septal defect with right pulmonary agenesis and left bronchial stenosis]. Kyobu Geka (2006) 0.75
Structural-electronic correlation in the first-order phase transition of [FeH2L2-Me](ClO4)2 (H2L2-Me = bis[((2-methylimidazol-4-yl)methylidene)-3- aminopropyl]ethylenediamine). Inorg Chem (2006) 0.75
Early and late results of entire septal patch technique for post infarction ventricular septal rupture. Gen Thorac Cardiovasc Surg (2012) 0.75
A surgical case of apical aneurysm without hypertrophic cardiomyopathy. Ann Thorac Cardiovasc Surg (2012) 0.75
Emergent combined repairs for aortic injury and bowel perforation after blunt trauma. Gen Thorac Cardiovasc Surg (2012) 0.75
Path-loss estimation of wireless channels in capsule endoscopy from X-ray CT images. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Large cardiac lipoma with pseudoaneurysmal appearance. J Am Coll Cardiol (2012) 0.75
[Acute massive pulmonary thromboembolism with cardiac arrest]. Kyobu Geka (2011) 0.75